Decision-making in polydrug amphetamine-type stimulant users: An fMRI study

Neuropsychopharmacology

Volumn 38, Issue 8, 2013, Pages 1377-1386

  Koester, Philip ^a   Volz, Kirsten G ^b   Tittgemeyer, Marc ^c   Wagner, Daniel ^a   Becker, Benjamin ^a   Gouzoulis Mayfrank, Euphrosyne ^a   Daumann, Joerg ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

addiction; amphetamine; decision making; functional magnetic resonance imaging; MDMA; reward processing

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE;

ADULT; ARTICLE; BEHAVIORAL RESEARCH; BRAIN FUNCTION; CLINICAL ARTICLE; CLINICAL DECISION MAKING; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EXPOSURE; FEMALE; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GAMBLING; HUMAN; LOW RISK POPULATION; MALE; MULTIPLE DRUG ABUSE; PRIORITY JOURNAL; PROBABILITY; REWARD;

ADOLESCENT; ADULT; AMPHETAMINES; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; DECISION MAKING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; REWARD; YOUNG ADULT;

EID: 84879414683     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2013.43     Document Type: Article

References (51)

1. Aron JL, Paulus MP (2007). Location, location: using functional magnetic resonance imaging to pinpoint brain differences relevant to stimulant use. Addiction 102(Suppl 1): 33-43. (Pubitemid 46328216)
2. Becker B, Wagner D, Koester P, Bender K, Kabbasch C, Gouzoulis-Mayfrank E et al (2012). Memory-related hippocampal functioning in ecstasy and amphetamine users: a prospective fMRI study. Psychopharmacology (Berl) 225: 923-934.
3. Bedi G, Phan KL, Angstadt M, de Wit H (2009). Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology (Berl) 207: 73-83.
4. Bolla KI, Eldreth DA, London ED, Kiehl KA, Mouratidis M, Contoreggi C et al (2003). Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage 19: 1085-1094. (Pubitemid 36918246)
5. Bolla KI, Eldreth DA, Matochik JA, Cadet JL (2005). Neural substrates of faulty decision-making in abstinent marijuana users. Neuroimage 26: 480-492. (Pubitemid 40719826)
6. Cowan RL, Lyoo IK, Sung SM, Ahn KH, Kim MJ, Hwang J et al (2003). Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study. Drug Alcohol Depend 72: 225-235. (Pubitemid 37485899)
7. Cservenka A, Nagel BJ (2012). Risky decision-making: an FMRI study of youth at high risk for alcoholism. Alcohol Clin Exp Res 36: 604-615.
8. Daumann J, Fischermann T, Heekeren K, Henke K, Thron A, Gouzoulis-Mayfrank E (2005). Memory-related hippocampal dysfunction in poly-drug ecstasy (3, 4-methylenedioxymetham-phetamine) users. Psychopharmacology (Berl) 180: 607-611. (Pubitemid 41317857)
9. Daumann J, Koester P, Becker B, Wagner D, Imperati D, Gouzoulis-Mayfrank E et al (2011). Medial prefrontal gray matter volume reductions in users of amphetamine-type stimulants revealed by combined tract-based spatial statistics and voxel-based morphometry. Neuroimage 54: 794-801.
10. De Win MM, Jager G, Booij J, Reneman L, Schilt T, Lavini C et al (2008). Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brain 131(Pt 11): 2936-2945.
11. Ersche KD, Fletcher PC, Lewis SJ, Clark L, Stocks-Gee G, London M et al (2005). Abnormal frontal activations related to decision-making in current and former amphetamine and opiate dependent individuals. Psychopharmacology (Berl) 180: 612-623. (Pubitemid 41317858)
12. Figee M, Vink M, de Geus F, Vulink N, Veltman DJ, Westenberg H et al (2011). Dysfunctional reward circuitry in obsessive-compulsive disorder. Biol Psychiatry 69: 867-874.
13. Gallinat J, Meisenzahl E, Jacobsen LK, Kalus P, Bierbrauer J, Kienast T et al (2006). Smoking and structural brain deficits: a volumetric MR investigation. Eur J Neurosci 24: 1744-1750. (Pubitemid 44427543)
14. Hanson KL, Luciana M, Sullwold K (2008). Reward-related decision-making deficits and elevated impulsivity among MDMA and other drug users. Drug Alcohol Depend 96: 99-110.
15. Hutton C, Draganski B, Ashburner J, Weiskopf N (2009). A comparison between voxel-based cortical thickness and voxel-based morphometry in normal aging. Neuroimage 48: 371-380.
16. Jenkinson M, Bannister P, Brady M, Smith S (2002). Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17: 825-841. (Pubitemid 35317016)
17. Jenkinson M, Smith S (2001). A global optimisation method for robust affine registration of brain images. Med Image Anal 5: 143-156. (Pubitemid 35282800)
18. Kalivas PW, Volkow ND (2005). The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162: 1403-1413. (Pubitemid 41105554)
19. Kish SJ, Lerch J, Furukawa Y, Tong J et al (2010). Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/((11)C)DASB and structural brain imaging study. Brain 133(Pt 6): 1779-1797.
20. Knutson B, Adams CM, Fong GW, Hommer D (2001). Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J Neurosci 21: RC159.
21. Koester P, Tittgemeyer M, Wagner D, Becker B, Gouzoulis-Mayfrank E, Daumann J (2012). Cortical thinning in amphetamine-type stimulant users. Neuroscience 221: 182-192.
22. Koob GF, Simon EJ (2009). The neurobiology of addiction: where we have been and where we are going. J Drug Issues 39: 115-132.
23. Kuhn S, Schubert F, Gallinat J (2010). Reduced thickness of medial orbitofrontal cortex in smokers. Biol Psychiatry 68: 1061-1065.
24. Lawyer G, Bjerkan PS, Hammarberg A, Jayaram-Lindstrom N, Franck J, Agartz I (2010). Amphetamine dependence and co-morbid alcohol abuse: associations to brain cortical thickness. BMC Pharmacol 10: 5.
25. Mechtcheriakov S, Brenneis C, Egger K, Koppelstaetter F, Schocke M, Marksteiner J (2007). A widespread distinct pattern of cerebral atrophy in patients with alcohol addiction revealed by voxel-based morphometry. J Neurol Neurosurg Psychiatry 78: 610-614. (Pubitemid 46853896)
26. Moeller FG, Steinberg JL, Lane SD, Buzby M, Swann AC, Hasan KM et al (2007). Diffusion tensor imaging in MDMA users and controls: association with decision making. Am J Drug Alcohol Abuse 33: 777-789. (Pubitemid 350125770)
27. Murphy PN, Bruno R, Ryland I, Wareing M, Fisk JE, Montgomery C et al (2012). The effects of ecstasy' (MDMA) on visuospatial memory performance: findings from a systematic review with meta-analyses. Hum Psychopharmacol 27: 113-138.
28. Paulus MP, Hozack N, Frank L, Brown GG, Schuckit MA (2003). Decision making by methamphetamine-dependent subjects is associated with error-rate-independent decrease in prefrontal and parietal activation. Biol Psychiatry 53: 65-74. (Pubitemid 36050937)
29. Paulus MP, Tapert SF, Schuckit MA (2005). Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse. Arch Gen Psychiatry 62: 761-768. (Pubitemid 41002757)
30. Quednow BB, Kuhn KU, Hoppe C, Westheide J, Maier W, Daum I et al (2007). Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ('Ecstasy'). Psychopharma-cology (Berl) 189: 517-530. (Pubitemid 44791221)
31. Roberts GM, Garavan H (2010). Evidence of increased activation underlying cognitive control in ecstasy and cannabis users. Neuroimage 52: 429-435.
32. Roesch MR, Olson CR (2004). Neuronal activity related to reward value and motivation in primate frontal cortex. Science 304: 307-310. (Pubitemid 38452186)
33. Rogers RD, Everitt BJ, Baldacchino A, Blackshaw AJ, Swainson R, Wynne K et al (1999). Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoami-nergic mechanisms. Neuropsychopharmacology 20: 322-339. (Pubitemid 29099763)
34. Rogers RD, Ramnani N, Mackay C, Wilson JL, Jezzard P, Carter CS et al (2004). Distinct portions of anterior cingulate cortex and medial prefrontal cortex are activated by reward processing in separable phases of decision-making cognition. Biol Psychiatry 55: 594-602. (Pubitemid 38315033)
35. Rogers RD, Tunbridge EM, Bhagwagar Z, Drevets WC, Jezzard P, Carter CS et al (2003). Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues. Neuropsychopharmacology 28: 153-162.
36. Rolls ET (2004). The functions of the orbitofrontal cortex. Brain Cogn 55: 11-29. (Pubitemid 38591427)
37. Schilt T, Goudriaan AE, Koeter MW, van den Brink W, Schmand B (2009). Decision making as a predictor of first ecstasy use: a prospective study. Psychopharmacology (Berl) 203: 519-527.
38. Schoenbaum G, Roesch MR, Stalnaker TA (2006). Orbitofrontal cortex, decision-making and drug addiction. Trends Neurosci 29: 116-124. (Pubitemid 43202601)
39. Schoenbaum G, Shaham Y (2008). The role of orbitofrontal cortex in drug addiction: a review of preclinical studies. Biol Psychiatry 63: 256-262.
40. Smerdon MJ, Francis AJ (2011). Reward sensitivity and outcome expectancies as predictors of ecstasy use in young adults. Addict Behav 36: 1337-1340.
41. Smith SM (2002). Fast robust automated brain extraction. Hum Brain Mapp 17: 143-155. (Pubitemid 35253488)
42. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H et al (2004). Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23(Suppl 1): S208-S219. (Pubitemid 39421720)
43. Studer B, Apergis-Schoute AM, Robbins TW, Clark L (2012). What are the odds? The neural correlates of active choice during gambling. Front Neurosci 6: 46.
44. Tobler PN, Christopoulos GI, O'Doherty JP, Dolan RJ, Schultz W (2009). Risk-dependent reward value signal in human prefrontal cortex. Proc Natl Acad Sci USA 106: 7185-7190
45. UNODC (2011): 2011 Global ATS Assessment. United Nations Publication http://www.unodc.org/documents/ATS/ATS-Globa-l-Assessment-2011.pdf.
46. van Hell HH, Vink M, Ossewaarde L, Jager G, Kahn RS, Ramsey NF (2010). Chronic effects of cannabis use on the human reward system: an fMRI study. Eur Neuropsychopharmacol 20: 153-163.
47. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F (2009). Imaging dopamine's role in drug abuse and addiction. Neuropharmacol-ogy 56(Suppl 1): 3-8.
48. Wagner D, Becker B, Koester P, Gouzoulis-Mayfrank E, Daumann J (2012). A prospective study of learning, memory, and executive function in new MDMA users. Addiction 108: 136-145.
49. Woolrich MW, Jbabdi S, Patenaude B, Chappell M, Makni S, Behrens T et al (2009). Bayesian analysis of neuroimaging data in FSL. Neuroimage 45(Suppl 1): S173-S186.
50. Woolrich MW, Ripley BD, Brady M, Smith SM (2001). Temporal autocorrelation in univariate linear modeling of FMRI data. Neuroimage 14: 1370-1386. (Pubitemid 33124185)
51. Worsley KJ, Evans AC, Marrett S, Neelin P (1992). A three-dimensional statistical analysis for CBF activation studies in human brain. J Cereb Blood Flow Metab 12: 900-918.